Opicapone

Opicapone is a prescription medication that is used to treat Parkinson's disease. It is a catechol-O-methyl transferase (COMT) inhibitor, which works by blocking the breakdown of naturally occurring substances in the brain, such as dopamine. This helps to improve the symptoms of Parkinson's disease, such as tremors, stiffness, and slow movements. It is taken orally, usually once a day.

Opicapone, sold under the brand name Ongentys, is a medication used specifically to manage Parkinson's disease, particularly the "wearing-off" symptoms [1]. Let's delve into its key features:

Function:

• Opicapone belongs to a drug class called catechol-O-methyltransferase (COMT) inhibitors [1, 2].
• Parkinson's disease is associated with a deficiency of dopamine, a brain chemical crucial for movement control.
• Levodopa, a standard Parkinson's treatment, helps replenish dopamine. However, the body naturally breaks down levodopa over time.
• Opicapone comes in here. It blocks the COMT enzyme, which is responsible for levodopa breakdown. This allows levodopa to stay active for a longer duration, improving movement and reducing "off" periods.

Administration:

• Opicapone is taken orally, typically once daily at bedtime on an empty stomach [1, 4].
• Maintaining a consistent dosing schedule is crucial for optimal benefit.

Benefits:

• By extending levodopa's effects, Opicapone helps improve "on" time in Parkinson's patients, reducing tremors, stiffness, and slowness [1].
• It can significantly enhance motor fluctuations compared to a placebo [2].